A detailed history of Wealth Alliance transactions in Argenx Se stock. As of the latest transaction made, Wealth Alliance holds 654 shares of ARGX stock, worth $410,921. This represents 0.04% of its overall portfolio holdings.

Number of Shares
654
Previous 628 4.14%
Holding current value
$410,921
Previous $270,000 31.11%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$434.22 - $551.9 $11,289 - $14,349
26 Added 4.14%
654 $354,000
Q2 2024

Aug 09, 2024

BUY
$356.01 - $451.55 $10,324 - $13,094
29 Added 4.84%
628 $270,000
Q1 2024

May 10, 2024

BUY
$356.95 - $413.29 $213,813 - $247,560
599 New
599 $235,000
Q3 2023

Nov 09, 2023

BUY
$369.35 - $548.43 $155,865 - $231,437
422 New
422 $207,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Wealth Alliance Portfolio

Follow Wealth Alliance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance with notifications on news.